Champions Oncology
CSBR
44 hedge funds and large institutions have $66.1M invested in Champions Oncology in 2020 Q2 according to their latest regulatory filings, with 17 funds opening new positions, 17 increasing their positions, 4 reducing their positions, and 4 closing their positions.
325% more first-time investments, than exits
New positions opened: 17 | Existing positions closed: 4
325% more repeat investments, than reductions
Existing positions increased: 17 | Existing positions reduced: 4
38% more capital invested
Capital invested by funds: $47.8M → $66.1M (+$18.3M)
38% more funds holding
Funds holding: 32 → 44 (+12)
3.77% more ownership
Funds ownership: 54.39% → 58.16% (+3.8%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$2.45M |
| 2 |
OMC
Overbrook Management Corp
New York
|
+$978K |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$916K |
| 4 |
HIM
Hillsdale Investment Management
Toronto,
Ontario, Canada
|
+$712K |
| 5 |
State Street
Boston,
Massachusetts
|
+$614K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
-$2.22M |
| 2 |
ISL
Ingalls & Snyder LLC
New York
|
-$987K |
| 3 |
MAG
Millrace Asset Group
Berwyn,
Pennsylvania
|
-$240K |
| 4 |
AIM
Alambic Investment Management
Belvedere,
California
|
-$86K |
| 5 |
CAM
ClariVest Asset Management
San Diego,
California
|
-$28.1K |
CSBR Hedge Fund Activity: Q2 2020 in Review
44 of the 4,888 institutional investors tracked by Wall St. Rank reported a position in Champions Oncology (CSBR) for Q2 2020, worth a combined $66.1M — up 38% from $47.8M a quarter earlier.
Buyers outnumbered sellers: 17 funds opened new CSBR positions and 4 closed out — a net gain of 13 holders — while 17 added to existing stakes and 4 trimmed.
The largest buyer was BlackRock, adding an estimated $2.45M. The largest seller was Cowen Prime Advisors, exiting entirely with an estimated $2.22M sold.
- 44 institutional investors held Champions Oncology (CSBR) as of Q2 2020, up from 32 in Q1 2020.
- Funds reported $66.1M of Champions Oncology stock for Q2 2020, up 38% quarter-over-quarter.
- 17 funds opened new Champions Oncology positions in Q2 2020 and 4 closed out, a net change of +13 holders.
- The largest Champions Oncology buyer in Q2 2020 was BlackRock, an estimated $2.45M added.
- The largest Champions Oncology seller in Q2 2020 was Cowen Prime Advisors, an estimated $2.22M sold.
Based on aggregated 13F filings for Q2 2020.